Vimarsana
Biggest News Aggregation in the World

Sutter Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sutter Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sutter Capital Today - Breaking & Trending Today

Glaukos Co. (NYSE:GKOS) Director Sells $560,000.00 in Stock - Vimarsana News

Glaukos Co. (NYSE:GKOS) Director Sells $560,000.00 in Stock

Glaukos Co. (NYSE:GKOS – Get Free Report) Director Gilbert H. Kliman sold 5,000 shares of the business’s stock in a transaction dated Thursday, May 30th. The stock was sold at an average price of $112.00, for a total transaction of $560,000.00. Following the completion of the sale, the director now owns 30,620 shares in the […]

StockNews.com Initiates Coverage on HomeStreet (NASDAQ:HMST) - Vimarsana News

StockNews.com Initiates Coverage on HomeStreet (NASDAQ:HMST)

Analysts at StockNews.com started coverage on shares of HomeStreet (NASDAQ:HMST – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the financial services provider’s stock. Several other research firms have also commented on HMST. Wedbush boosted their price target on shares of HomeStreet from $15.00 to $16.00 […]

Glaukos (NYSE:GKOS) Price Target Raised to $110.00 - Vimarsana News

Glaukos (NYSE:GKOS) Price Target Raised to $110.00

Glaukos (NYSE:GKOS – Free Report) had its price target upped by JPMorgan Chase & Co. from $108.00 to $110.00 in a research report report published on Thursday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical instruments supplier’s stock. Several other research firms also recently commented on GKOS. Citigroup boosted […]

Source: wkrb13.com
Coombe Bender & Co LLC Takes $334,000 Position in Pfizer Inc. (NYSE:PFE) - Vimarsana News

Coombe Bender & Co LLC Takes $334,000 Position in Pfizer Inc. (NYSE:PFE)

Coombe Bender & Co LLC bought a new stake in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 11,584 shares of the biopharmaceutical company’s stock, valued at approximately $334,000. Other institutional investors and hedge funds have […]

Van ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE) - Vimarsana News

Van ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE)

Van ECK Associates Corp lifted its position in Pfizer Inc. (NYSE:PFE – Free Report) by 33.6% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,984,150 shares of the biopharmaceutical company’s stock after acquiring an additional 3,265,276 shares during the period. Van ECK Associates Corp owned […]